FDA Brief

Warning letters Drugs

FDA warning letter to

PowerAll Pharma

High riskIssued Aug 31, 2021Posted Sep 3, 2021

FDA warned PowerAll Pharma for selling unapproved, misbranded opioid and benzodiazepine drugs online without prescriptions.

What happened

FDA reviewed PowerAll Pharma’s websites and found it offered tramadol, oxymorphone (Opana ER), and diazepam (Valium) for sale to U.S. consumers. FDA said these are unapproved new drugs and are misbranded because their labeling lacks adequate directions and they are prescription drugs offered without requiring a prescription. This was based on a website review, not an inspection.

What FDA found

  1. PowerAll Pharma offered tramadol, oxymorphone, and diazepam as new drugs without FDA-approved applications.

    FD&C Act sections 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. The drug labeling did not give adequate directions for a layperson to use the products safely.

    FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. PowerAll Pharma offered prescription drugs without requiring a prescription, which misbrands the drugs.

    FD&C Act sections 503(b)(1), 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]
  4. PowerAll Pharma caused unapproved and misbranded drugs to be introduced into interstate commerce through its websites.

    FD&C Act sections 301(a), 301(d), 301(k), 503(b), 505(a) [21 U.S.C. §§ 331(a), 331(d), 331(k), 353(b), 355(a)]

What FDA wants

FDA tells PowerAll Pharma to stop offering any violative drugs for sale to U.S. consumers and to respond in writing within 15 working days describing corrective steps and how it will prevent recurrence.

Who should pay attention

  • online pharmacies selling prescription opioids or benzodiazepines
  • services hosting or processing payments for such websites
  • consumers buying prescription drugs online

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk